Literature DB >> 6803306

Variables associated with radioimmunoassay of prostaglandins in plasma.

H G Morris, N A Sherman, F T Shepperdson.   

Abstract

This study examined a number of variables which influence radio-immunoassay measurements of prostaglandins in plasma. Comparative assays in specimens obtained from normal subjects and processed by different methods demonstrated that prostaglandin measurements were uniformly lower when blood was anticoagulated with EDTA, aspirin or indomethacin was added to inhibit further synthesis or prostaglandins in vitro, samples were centrifuged at 4 degrees C at speeds which removed platelets from the sample, and assays were performed when plasma was thawed for the first time. Examination of assay results also revealed that the presence of unextracted plasma enhanced the binding of labeled ligands to antisera (%Bo) but thereafter, the displacement of ligand by increasing quantities of the reference prostaglandin paralleled the results in buffer throughout the range of the assay. In subsequent studies therefore the %Bo for plasma assays was adjusted on the basis of ligand binding in the presence of comparable volumes of pooled plasma from aspirin-treated subjects. Results of 7 prostaglandin assays in plasma and serum of normal subjects are reported.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6803306     DOI: 10.1016/0090-6980(81)90234-3

Source DB:  PubMed          Journal:  Prostaglandins        ISSN: 0090-6980


  11 in total

1.  Determination of peripheral plasma prostanoid concentration: an unreliable index of 'in vivo' prostanoid activity.

Authors:  H Schweer; J Kammer; P G Kühl; H W Seyberth
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

2.  A role for thromboxane in complement-mediated glomerular injury.

Authors:  A V Cybulsky; W Lieberthal; R J Quigg; H G Rennke; D J Salant
Journal:  Am J Pathol       Date:  1987-07       Impact factor: 4.307

3.  Lung function and plasma levels of thromboxane B2, 6-ketoprostaglandin F1 alpha and beta-thromboglobulin in antigen-induced asthma before and after indomethacin pretreatment.

Authors:  E G Shephard; L Malan; C M Macfarlane; W Mouton; J R Joubert
Journal:  Br J Clin Pharmacol       Date:  1985-04       Impact factor: 4.335

4.  Lidocaine inhibition of esophageal peristalsis and lower esophageal sphincter pressure in baboons.

Authors:  D R Sinar; L C Carey; C Cordova; J R Fletcher; D O Castell
Journal:  Dig Dis Sci       Date:  1985-11       Impact factor: 3.199

5.  [Thrombocyte function and thrombocyte-associated immunoglobulins in patients with systemic lupus erythematosus and chronic polyarthritis].

Authors:  A Horn; H J Avenarius; H Deicher
Journal:  Klin Wochenschr       Date:  1990-05-04

6.  Acetyl glyceryl ether phosphorylcholine-stimulated human platelets cause pulmonary hypertension and edema in isolated rabbit lungs. Role of thromboxane A2.

Authors:  J E Heffner; S A Shoemaker; E M Canham; M Patel; I F McMurtry; H G Morris; J E Repine
Journal:  J Clin Invest       Date:  1983-02       Impact factor: 14.808

7.  Plasma levels and urinary excretion of prostaglandins in patients with rheumatoid arthritis.

Authors:  O Laitinen; E Seppalä; M Nissilä; H Vapaatalo
Journal:  Clin Rheumatol       Date:  1983-12       Impact factor: 2.980

8.  Oxygen metabolites stimulate thromboxane production and vasoconstriction in isolated saline-perfused rabbit lungs.

Authors:  R M Tate; H G Morris; W R Schroeder; J E Repine
Journal:  J Clin Invest       Date:  1984-08       Impact factor: 14.808

9.  Thromboxane and prostacyclin release in adult respiratory distress syndrome.

Authors:  G Deby-Dupont; M Braun; M Lamy; C Deby; J Pincemail; M E Faymonville; P Damas; L Bodson; M P Lecart; R Goutier
Journal:  Intensive Care Med       Date:  1987       Impact factor: 17.440

10.  Endogenous biosynthesis of prostacyclin and thromboxane and platelet function during chronic administration of aspirin in man.

Authors:  G A FitzGerald; J A Oates; J Hawiger; R L Maas; L J Roberts; J A Lawson; A R Brash
Journal:  J Clin Invest       Date:  1983-03       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.